Literature DB >> 10397259

Characterization of the GAGE genes that are expressed in various human cancers and in normal testis.

O De Backer1, K C Arden, M Boretti, V Vantomme, C De Smet, S Czekay, C S Viars, E De Plaen, F Brasseur, P Chomez, B Van den Eynde, T Boon, P van der Bruggen.   

Abstract

The GAGE-1 gene was identified previously as a gene that codes for an antigenic peptide, YRPRPRRY, which was presented on a human melanoma by HLA-Cw6 molecules and recognized by a clone of CTLs derived from the patient bearing the tumor. By screening a cDNA library from this melanoma, we identified five additional, closely related genes named GAGE-2-6. We report here that further screening of this library led to the identification of two more genes, GAGE-7B and -8. GAGE-1, -2, and -8 code for peptide YRPRPRRY. Using another antitumor CTL clone isolated from the same melanoma patient, we identified antigenic peptide, YYWPRPRRY, which is encoded by GAGE-3, -4, -5, -6, and -7B and which is presented by HLA-A29 molecules. Genomic cloning of GAGE-7B showed that it is composed of five exons. Sequence alignment showed that an additional exon, which is present only in the mRNA of GAGE-1, has been disrupted in gene GAGE-7B by the insertion of a long interspersed repeated element retroposon. These GAGE genes are located in the p11.2-p11.4 region of chromosome X. They are not expressed in normal tissues, except in testis, but a large proportion of tumors of various histological origins express at least one of these genes. Treatment of normal and tumor cultured cells with a demethylating agent, azadeoxycytidine, resulted in the transcriptional activation of GAGE genes, suggesting that their expression in tumors results from a demethylation process.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10397259

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  39 in total

Review 1.  Immunotherapy of melanoma.

Authors:  C Smith; V Cerundolo
Journal:  Immunology       Date:  2001-09       Impact factor: 7.397

2.  Expression of cancer-testis (CT) antigens in placenta.

Authors:  Achim A Jungbluth; Wilson A Silva; Kristin Iversen; Denise Frosina; Bushra Zaidi; Keren Coplan; Susannah K Eastlake-Wade; Sandra B Castelli; Giulio C Spagnoli; Lloyd J Old; Martin Vogel
Journal:  Cancer Immun       Date:  2007-08-24

3.  Global analysis of biogenesis, stability and sub-cellular localization of lncRNAs mapping to intragenic regions of the human genome.

Authors:  Ana C Ayupe; Ana C Tahira; Lauren Camargo; Felipe C Beckedorff; Sergio Verjovski-Almeida; Eduardo M Reis
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

Review 4.  The evolution of the EGFRvIII (rindopepimut) immunotherapy for glioblastoma multiforme patients.

Authors:  Michelle Paff; Daniela Alexandru-Abrams; Frank P K Hsu; Daniela A Bota
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

5.  Configuration and rearrangement of the human GAGE gene clusters.

Authors:  Michael W Killen; Tiffany L Taylor; Dawn M Stults; Weidong Jin; Lisa L Wang; Jeffrey A Moscow; Andrew J Pierce
Journal:  Am J Transl Res       Date:  2011-05-08       Impact factor: 4.060

6.  Using protein microarray as a diagnostic assay for non-small cell lung cancer.

Authors:  Li Zhong; Giovanna E Hidalgo; Arnold J Stromberg; Nada H Khattar; James R Jett; Edward A Hirschowitz
Journal:  Am J Respir Crit Care Med       Date:  2005-08-18       Impact factor: 21.405

7.  Cancer-testis specific gene OIP5: a downstream gene of E2F1 that promotes tumorigenesis and metastasis in glioblastoma by stabilizing E2F1 signaling.

Authors:  Jiang He; Yuzu Zhao; Erhu Zhao; Xianxing Wang; Zhen Dong; Yibiao Chen; Liqun Yang; Hongjuan Cui
Journal:  Neuro Oncol       Date:  2018-08-02       Impact factor: 12.300

8.  Combinatorial pharmacologic approaches target EZH2-mediated gene repression in breast cancer cells.

Authors:  Feng Sun; Eli Chan; Zhenlong Wu; Xiaojing Yang; Victor E Marquez; Qiang Yu
Journal:  Mol Cancer Ther       Date:  2009-12       Impact factor: 6.261

9.  Role of human noncoding RNAs in the control of tumorigenesis.

Authors:  Ling Li; Tingting Feng; Yingying Lian; Guangfeng Zhang; Alan Garen; Xu Song
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-22       Impact factor: 11.205

10.  Agglomerative epigenetic aberrations are a common event in human breast cancer.

Authors:  Petr Novak; Taylor Jensen; Marc M Oshiro; George S Watts; Christina J Kim; Bernard W Futscher
Journal:  Cancer Res       Date:  2008-10-15       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.